Browse Pet Safety Reports
969,382 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 969,382 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 969,382 FDA veterinary adverse event reports for Dog.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Feb 27, 2026 | Dog | Sheepdog - Shetland | Moxidectin | Limping; Bloody diarrhoea | Ongoing |
| Feb 27, 2026 | Dog | Great Pyrenees | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Feb 27, 2026 | Dog | Retriever - Labrador | Fluralaner Powder For Inj Susp | Lethargy (see also Central nervous system depression in Neurological); Emesis... | Ongoing |
| Feb 27, 2026 | Dog | Shepherd Dog - Australian | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - heartworm; Other abnormal test result NOS; ... | Outcome Unknown |
| Feb 27, 2026 | Dog | Pit Bull | Afoxolaner 18.75Mg / Moxidectin 90Mcg... | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Feb 27, 2026 | Dog | Shepherd Dog - Australian, ... | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (endoparasite) - roundworm NOS | Outcome Unknown |
| Feb 27, 2026 | Dog | Chihuahua | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Feb 27, 2026 | Dog | Newfoundland | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - hookworm; Lack of efficacy (endoparasite) -... | Ongoing |
| Feb 27, 2026 | Dog | Retriever - Labrador, Dog (... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm; Medication error NOS | Ongoing |
| Feb 27, 2026 | Dog | Spaniel (unspecified) | Moxidectin | Not eating; Not himself/herself; Anaemia NOS; Other abnormal test result NOS;... | Ongoing |
| Feb 27, 2026 | Dog | Corgi - Welsh Pembroke | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - whipworm | Ongoing |
| Feb 26, 2026 | Dog | Shepherd Dog - German | Oclacitinib Maleate | Lack of efficacy - NOS | Ongoing |
| Feb 26, 2026 | Dog | Terrier - Jack Russell | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia; Intentional misuse | Ongoing |
| Feb 26, 2026 | Dog | Terrier - Tibetan | Sarolaner | Nausea; Lip licking; Drooling | Recovered/Normal |
| Feb 26, 2026 | Dog | Crossbred Canine/dog, Pit Bull | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea; Lack of efficacy (ectoparasite) - tic... | Ongoing |
| Feb 26, 2026 | Dog | Crossbred Canine/dog | Moxidectin | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 26, 2026 | Dog | Retriever - Labrador | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 26, 2026 | Dog | Terrier - Bull - American Pit | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 26, 2026 | Dog | Terrier - Yorkshire | Bedinvetmab | Pollakiuria; Seizure NOS | Ongoing |
| Feb 26, 2026 | Dog | Beagle, Dog (unknown) | Bedinvetmab | Vomiting; Ataxia; Inappropriate urination; Disorientation; Hearing decreased;... | Ongoing |
| Feb 26, 2026 | Dog | Shepherd (unspecified), Dog... | Oclacitinib Maleate | Seizure NOS | Ongoing |
| Feb 26, 2026 | Dog | Crossbred Canine/dog, Chihu... | Fluralaner Powder For Inj Susp | Injection site hair loss; Injection site reddening | Ongoing |
| Feb 26, 2026 | Dog | Cattle Dog - Australian (bl... | Bedinvetmab | Hind limb ataxia; Polyuria; Polydipsia; Weakness; Not eating; Elevated blood ... | Ongoing |
| Feb 26, 2026 | Dog | Crossbred Canine/dog | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea; Lack of efficacy (ectoparasite) - tic... | Ongoing |
| Feb 26, 2026 | Dog | Collie - Border | Pyrantel Pamoate;Sarolaner | Aggression; Behavioural disorder NOS; Shaking; Diarrhoea; Decreased appetite;... | Recovered/Normal |
| Feb 26, 2026 | Dog | Pit Bull | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (protozoa) - Giardia; Lack of efficacy (endoparasite) - roun... | Outcome Unknown |
| Feb 26, 2026 | Dog | Crossbred Canine/dog, Sheph... | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 25, 2026 | Dog | Maltese, Terrier - Yorkshire | Cefpodoxime Proxetil | Application site inflammation; Application site reddening | Outcome Unknown |
| Feb 25, 2026 | Dog | Retriever - Labrador | Oclacitinib Maleate | Lack of efficacy - NOS | Ongoing |
| Feb 25, 2026 | Dog | Collie (unspecified), Dog (... | Bedinvetmab | Drooling; Cough; Panting | Ongoing |
| Feb 25, 2026 | Dog | Pointing Dog - German Short... | Bedinvetmab | Lack of efficacy - NOS; Pain NOS; Circling - neurological disorder (see also ... | Ongoing |
| Feb 25, 2026 | Dog | Pug, Beagle | Maropitant Citrate | Vomiting; Discomfort NOS; Mopey; Not eating | Ongoing |
| Feb 25, 2026 | Dog | Crossbred Canine/dog | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Dog | Crossbred Canine/dog | Bedinvetmab | Musculoskeletal disorder NOS; Aggression; Unable to walk; Urinary incontinenc... | Euthanized |
| Feb 25, 2026 | Dog | Bulldog - English, Dog (unk... | Bedinvetmab | Injection site pain; Injection site swelling; Lethargy (see also Central nerv... | Died |
| Feb 25, 2026 | Dog | Spaniel - King Charles Cava... | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Lack of efficacy (endoparasite) - hookworm | Outcome Unknown |
| Feb 25, 2026 | Dog | Terrier - Bull - American P... | Bedinvetmab | Cognitive disorder NOS; Behavioural disorder NOS; Staring; Confusion | Ongoing |
| Feb 25, 2026 | Dog | Crossbred Canine/dog, Retri... | Fluralaner Powder For Inj Susp | Head shake - behavioural disorder; Pruritus; Soft stool; Blood in faeces; Col... | Recovered with Sequela |
| Feb 25, 2026 | Dog | Spaniel - Cocker English | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Dog | Boxer (German Boxer) | Carprofen | Injection site swelling | Outcome Unknown |
| Feb 25, 2026 | Dog | Bulldog - French | Moxidectin | Emesis (multiple); Facial swelling (see also Skin); Hypersensitivity reaction... | Ongoing |
| Feb 25, 2026 | Dog | Spaniel - King Charles Cava... | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Feb 25, 2026 | Dog | Crossbred Canine/dog | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Dog | Dog (unknown) | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Feb 25, 2026 | Dog | Shepherd Dog - German | Afoxolaner 150Mg / Moxidectin 720Mcg ... | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 25, 2026 | Dog | Shepherd Dog - German | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Feb 24, 2026 | Dog | Collie - Border | Pyrantel Pamoate;Sarolaner | Ataxia; Vomiting | Recovered/Normal |
| Feb 24, 2026 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Emesis (multiple); Itching; Diarrhoea | Outcome Unknown |
| Feb 24, 2026 | Dog | Pointing Dog - German (unsp... | Lotilaner,Moxidectin,Praziquantel,Pyr... | Star-gazing | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.